Biomarker World Congress 2018
Cambridge Healthtech Institute's Fourteenth Annual Biomarkers and Immuno-Oncology World Congress, now in Boston, is our longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, using biomarkers to choose rational combination immunotherapy, and applying immune profiling to predict and monitor response to immunotherapy. The Immuno-Oncology Biomarkers stream will address predictive biomarkers and companion diagnostics, as well as immune profiling and immune monitoring. The Immunotherapy stream will address the two biggest challenges in pharmaceutical IO programs: designing rational combination immunotherapies and strategies to address intrinsic and acquired resistance. Finally, a new track on Digital Biomarkers will cover the clinical utility of biosensors, wearables and mobile health, and their emerging applications in drug development.
The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its fourteenth year, the Biomarkers and Immuno-Oncology World Congress is the leading annual meeting dedicated to biomarkers, diagnostics, and immuno-oncology research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.
Please join us in Boston for comprehensive scientific coverage and unparalleled networking opportunities at the Fourteenth AnnualBiomarkers and Immuno-Oncology World Congress 2018!
Typical CHI event attendees include: C-Level Executives, Directors, Research Scientists, and Managers/Senior Scientists from Biotech, Pharmaceutical, Academia, and Hospitals.
Intimate, targeted events that allow you to meet and influence senior level scientists, executives, and decision makers. Develop new business leads via our networking events and participation in our Break-out Sessions. Revisit existing customers, support & strengthen the relationship for future growth. Brand your company name and generate awareness of your corporate image.